Skip to main content

Advertisement

SpringerLink
Log in

Rebamipide Enema is Effective for Treatment of Experimental Dextran Sulfate Sodium Induced Colitis in Rats

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We investigated therapeutic efficacy of rebamipide using dextran sulfate sodium (DSS) induced colitis model in rats. Three percent DSS solution was given to rats for 9 days. After that, we evaluated the drug efficacy on colitis sustained with continuous drinking of 1% DSS. Twice-daily treatment with 0.3% or 1% rebamipide for 14 days significantly ameliorated the stool abnormality in the colitis model, preferentially suppressed hematochezia. The colonic mucosal lesion, determined by Alcian blue staining on day 24, was significantly reduced by rebamipide enema in a dose-dependent manner. Either rebamipide or 5-aminosalycilic acid (5-ASA) enema treated once daily significantly ameliorated colitis. The minimum effective dose of rebamipide was 0.3% in once-daily treatment, and that of 5-ASA was 10%. In a mechanistic study, the epithelial cell sheet formation of the T84 colon cancer cell was measured as an increase in generation of trans-epithelial electrical resistance in vitro. Rebamipide accelerated the increase, while 5-ASA conversely suppressed it. These results suggest that rebamipide enema is effective for treatment of experimental ulcerative colitis (UC).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Farmer RG: In JE Berk (ed). Bockus Gastroenterology, 4th ed. Philadelphia, WIS Saunders, 1985, pp 60

  2. Hibi T, Ogata H, Sakuraba A: Animal models of inflammatory bowel disease. J Gastroenterol 37:409–417, 2002

    Article  PubMed  Google Scholar 

  3. Ohkusa T: Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and change in intestinal microflora. Jpn J Gastroenterol 82:1327–1336, 1985

    Google Scholar 

  4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990

    PubMed  Google Scholar 

  5. Kimura I, Kamiya A, Nagahama S, Yoshida J, Tanigawa H, Kataoka M: Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rat: estimation of mucosal erosions by the alcian blue-staining method. Folia Pharmacol Jpn 102:343–350, 1993

    Google Scholar 

  6. Kimura I, Nagahama S, Kawasaki M, Kamiya A, Kataoka M: Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (2). Folia Pharmacol Jpn 105:145–152, 1995

    Google Scholar 

  7. Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M: Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3). Folia Pharmacol Jpn 108:259–266, 1996

    Google Scholar 

  8. Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S: Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 142:23–29, 1987

    Google Scholar 

  9. Uchida M, Tabusa F, Komatsu M, Morita S, Kanbe T, Nakagawa K: Studies on 2 (1H)-quinolinone derivatives as gastric antiulcer active agents. Synthesis and antiulcer activities of optically active alpha-amino acid derivatives of 2 (1H)-quinolinone and oxindole. Chem Pharm Bull (Tokyo) 35:853–856, 1987

    Google Scholar 

  10. Higuchi K, Arakawa T, Nebiki H, Uchida T, Fujiwara Y, Ando K, Yamasaki K, Takaishi O, Fukuda T, Kobayashi K, Kuroki T: Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. Dig Dis Sci 43:99S–106S, 1998

    PubMed  Google Scholar 

  11. Yoshikawa T, Naito Y, Tanigawa T, Kondo M: Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 43:363–366, 1993

    PubMed  Google Scholar 

  12. Nagano C, Wakebe H, Azuma A, Imagawa K, Kikuchi M: IFN-gamma-induced iNOS mRNA expression is inhibited by rebamipide in murine macrophage RAW264.7 cells. Dig Dis Sci 43:118S-124S, 1998

    PubMed  Google Scholar 

  13. Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M: Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci 43:160S–166S, 1998

    PubMed  Google Scholar 

  14. Yoshida N, Yoshikawa T, Iinuma S, Arai M, Takenaka S, Sakamoto K, Miyajima T, Nakamura Y, Yagi N, Naito Y, Mukai F, Kondo M: Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig Dis Sci 41:1139–1144, 1996

    Article  PubMed  Google Scholar 

  15. Kim CD, Kim YK, Lee SH, Hong KW: Rebamipide inhibits neutrophil adhesion to hypoxia/reoxygenation-stimulated endothelial cells via nuclear factor-kappa B-dependent pathway. J Pharmacol Exp Ther 294:864–869, 2000

    PubMed  Google Scholar 

  16. Yoshida M, Wakabayashi G, Ishikawa H, Kitahora T, Otani Y, Shimazu M, Miura S, Ishii H, Kitajima M: Rebamipide attenuates gastric microcirculatory disturbances in the early period after thermal injury in rats. Dig Dis Sci 43:148S–153S, 1998

    Article  PubMed  Google Scholar 

  17. Kobayashi T, Zinchuk VS, Garcia del Saz E, Jiang F, Yamasaki Y, Kataoka S, Okada T, Tsunawaki S, Seguchi H: Suppressive effect of rebamipide, an antiulcer agent, against activation of human neutrophils exposed to formyl-methionyl-leucyl-phenylalanine. Histol Histopathol 15:1067–1076, 2000

    PubMed  Google Scholar 

  18. Kim CD, Hong KW: Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. J Pharmacol Exp Ther 275:340–344, 1995

    PubMed  Google Scholar 

  19. Kleine A, Kluge S, Peskar BM: Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441–9, 1993

    Article  PubMed  Google Scholar 

  20. Sun WH, Tsuji S, Tsujii M, Gunawan ES, Kawai N, Kimura A, Kakiuchi Y, Yasumaru M, Iijima H, Okuda Y, Sasaki Y, Hori M, Kawano S: Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther 295:447–452, 2000

    PubMed  Google Scholar 

  21. Suetsugu H, Ishihara S, Moriyama N, Kazumori H, Adachi K, Fukuda R, Watanabe M, Kinoshita Y: Effect of rebamipide on prostaglandin EP4 receptor gene expression in rat gastric mucosa. J Lab Clin Med 136:50–57, 2000

    Article  PubMed  Google Scholar 

  22. Takahashi M, Takada H, Takagi K, Kataoka S, Soma R, Kuwayama H: Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide. Alim Pharmacol Ther 18:126–132, 2003

    Article  Google Scholar 

  23. Watanabe T, Higuchi K, Hamaguchi M, Tanigawa T, Wada R, Tominaga K, Fujiwara Y, Arakawa T: Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci 47:1582–1589, 2002

    Article  PubMed  Google Scholar 

  24. Zea-Iriarte WL, Makiyama K, Goto S, Murase K, Urata Y, Sekine I, Hara K, Kondo T: Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide. Scand J Gastroenterol 31:985–992, 1996

    PubMed  Google Scholar 

  25. Sakurai K, Osaka T, Yamasaki K: Protection by rebamipide against acetic acid-induced colitis in rats: relationship with its antioxidative activity. Dig Dis Sci 43:125S–133S, 1998

    PubMed  Google Scholar 

  26. Iwai A, Iwashita E: Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide. Dig Dis Sci 43:143S–147S, 1998

    PubMed  Google Scholar 

  27. Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y: Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 45:1608–1616, 2000

    Article  PubMed  Google Scholar 

  28. Makiyama K, Takeshima F, Kawasaki H, Zea-Iriarte WL: Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative. Am J Gastroenterol 95:1838–1839, 2000

    Article  PubMed  Google Scholar 

  29. Cooper HS, Murthy SNS, Shan RS, Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238–249, 1993

    PubMed  Google Scholar 

  30. Madara JL, Dharmsathaphorn K: Occluding junction structure–function relationships in a cultured epithelial monolayer. J Cell Biol 101:2124–2133, 1985

    Article  PubMed  Google Scholar 

  31. Madara JL, Stafford J: Structural analysis of a human intestinal epithelial cell line. Gastroenterology 92:1133–1145, 1987

    PubMed  Google Scholar 

  32. Tarnawski A, Arakawa T, Kobayashi K: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig Dis Sci 43:90S–98S, 1998

    Article  PubMed  Google Scholar 

  33. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A: Rebamipide: Overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig Dis Sci 43:5S–13S, 1998

    PubMed  Google Scholar 

  34. Banan A, Fitzpatrick L, Zhang Y, Keshavarzian A: OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability. Free Radic Biol Med 30:287–298, 2001

    Article  PubMed  Google Scholar 

  35. Prakash A, Markham A: Oral delayed-release mesalazine. A review of its use in ulcerative colitis and Crohn's disease. Drugs 57:383–408, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Institute of Pharmacological and Therapeutical Development, Otsuka Pharmaceutical Co. Ltd., 463-10 Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan

    Takako Nakashima BS, Takashi Maeda MS, Hisashi Nagamoto PhD, Takeshi Kumakura BS, Masaaki Takai DVM & Toyoki Mori DVM, PhD

Authors
  1. Takako Nakashima BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Maeda MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hisashi Nagamoto PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takeshi Kumakura BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaaki Takai DVM
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toyoki Mori DVM, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masaaki Takai DVM.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakashima, T., Maeda, T., Nagamoto, H. et al. Rebamipide Enema is Effective for Treatment of Experimental Dextran Sulfate Sodium Induced Colitis in Rats. Dig Dis Sci 50 (Suppl 1), S124–S131 (2005). https://doi.org/10.1007/s10620-005-2817-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2817-0

Key Words

Search

Navigation